Available online at
|
|
- Lora Robinson
- 5 years ago
- Views:
Transcription
1 60 Available online at Serum Angiopoietin-2 as a Clinical Marker for Lung Cancer in Patients with Solitary Pulmonary Nodules Chunhua Xu 1,2, Wei Wang 1,2, Yuchao Wang 1,2, Xiuwei Zhang 3, Jun Yan 4, and Like Yu 1,2 1 Endoscopic Center of Nanjing Chest Hospital, Nanjing, Jiangsu, 2 Clinical Center of Nanjing Respiratory Diseases and Imaging, Nanjing, Jiangsu, 3 Department of Respiratory Medicine, Nanjing Jiangning Hospital, Nanjing, Jiangsu, and 4 MOE Key Laboratory, Model Animal Research Center, Nanjing University, Nanjing, Jiangsu, China Abstract. To evaluate the clinical significance of angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF) in lung cancer patients with solitary pulmonary nodule (SPN). The study enrolled 128 patients with malignant SPN, 60 patients with benign SPN, along with 40 healthy volunteers. Serum concentrations of Ang-2 and VEGF were measured by ELISA. Serum Ang-2 and VEGF levels in patients with malignant SPN were significantly higher than those in patients with benign SPN (p<0.01), and those in healthy volunteers (p<0.05). With a cutoff of pg/ml, the sensitivity and specificity of Ang-2 in differentiating between patients with malignant SPN and patients with benign SPN, and between patients with malignant SPN and healthy volunteers was 69.5 and 92.5%, and 80.5 and 97.5%, respectively. Additionally, higher levels of Ang-2 were associated with higher tumor stage (p<0.05). The levels of Ang-2 correlated with the VEGF level (p<0.01). In conclusion, measurement of serum Ang-2 might be a useful diagnostic marker for SPN patients. Keywords: Angiopoietin-2, solitary pulmonary nodule, diagnosis, biomarker. Introduction Solitary pulmonary nodule (SPN) is a round or oval opacity smaller than 3 cm in diameter that is completely surrounded by pulmonary parenchyma and is not associated with lymphadenopathy, atelectasis, or pneumonia [1,2]. Most SPN are detected incidentally on chests X-rays or computerized tomography (CT) scans that are usually performed for some other purpose [3]. SPN can be divided into benign and malignant. The early differentiation of malignant from benign SPN is extremely critical because it represents a different approach regarding treatment and prediction of prognosis [4,5]. Some SPN are indicated pathologically in the early stages of lung cancers [6,7]. Identification of malignant nodules is crucial because they represent a localized and potentially curable form of lung cancer. A few plasma biomarkers have been used to screen and diagnose cancers [8-10]. Currently, there is no single convenient and reliable biomarker proven effective for the diagnosis of lung cancer [11]. Address correspondence to Like Yu, Endoscopic Center of Nanjing Chest Hospital, 215 Guangzhou Road, Nanjing, , China; phone/fax: ; e mail: lkyu54@126.com. Angiopoietins (Ang), novel endothelial factors, were found to be ligands for the endothelium-specific tyrosin kinase receptor Tie-2 [12]. Ang included Ang-1, Ang-2, Ang-3 and Ang-4, the best characterized were Ang-1 and Ang-2. Ang-2 was soluble 70-ku factors, which consist of an amino-terminal coiled-coil domain and a carboxy-terminal fibrinogen-like domain. Ang-2 is upregulated in various cancers, including lung cancer [13,14], and its expression is co-localized and correlated with that of VEGF [15]. Serum Ang-2 has also been reported to be increased in breast cancer [16], prostate cancer [16], thyroid cancer [17] and acute myeloid leukemia [18]. However, the serum levels of Ang-2 have not been evaluated in SPN. We measured the serum levels of Ang-2 and VEGF in SPN patients and assessed their interrelationship and clinical significance. Materials and Methods Patients. The study included 188 patients with SPN who were recruited from the Nanjing Chest Hospital from January 2009 to December The patients consisted of 128 individuals who had malignant SPN and 60 with benign SPN. Forty healthy volunteers without SPN were also recruited as controls. Tumors were /16/ by the Association of Clinical Scientists, Inc.
2 Table 1. The characteristics of patients with malignant SPN, patients with benign SPN, and healthy volunteers. Variables Malignant SPN Benign SPN Healthy volunteers p value Subject, NO Age, year 54.3± ± ±11.7 >0.05 Male/Female 80/48 35/25 18/12 >0.05 Malignant SPN ADC 72 SCC 48 SCLC 8 Benign SPN Tuberculosis 30 Granuloma 10 Inflammation 20 ADC, adenocarcinoma; SCC, squamous cell carcinoma; SCLC, small cell lung carcinoma. Table 2. Serum Ang-2 and VEGF levels in the three groups. Group Malignant SPN Benign SPN Healthy volunteers p value (n=124) (n=60) (n=40) Ang-2(pg/mL) ± ± ± * VEGF (pg/ml) 512.9± ± ± * *Significant difference. Angiopoietin-2 and Solitary Pulmonary Nodules 61 Table 3. Relationship between serum Ang-2 and VEGF levels and clinicopathological characteristics in malignant SPN. Characteristics All cases Ang-2 (pg/ml) p VEGF (pg/ml) p Age (years) ± ±124.4 > ± ±171.6 Gender Male ± ±169.2 Female ± ±116.7 Smoking condition Non-smoker ± ±171.4 Smoker ± ±117.9 Histology ADC ± ±172.6 SCC ± ±120.8 SCLC ± ±156.7 Differentiation Well-moderate ± ±166.0 Poor ± ±104.8 TNM stage 0.033* I ± ±164.2 II ± ±132.1 ADC, adenocarcinoma; SCC, squamous cell carcinoma; SCLC, small cell lung carcinoma. *Significant difference.
3 62 Figure 1. Levels of Ang-2 and VEGF in SPN. Among 128 malignant SPN patients, (A) the serum levels of Ang-2 were ( ±599.1) pg/ml, which were significantly higher than those of benign SPN group (1491.7±288.6) pg/ml and healthy volunteers group (1441.2±325.7) pg/ml (p<0.01), (B) the serum levels of VEGF were (512.9± 133.2) pg/ml, which were significantly higher than those of benign SPN group (421.9±121.7) pg/ml and healthy volunteers group (406.1±124.2) pg/ml (p<0.05). radiation). Samples were centrifuged at 1500 g for 10 min at -4 C. The supernatant was stored at -80 C. Enzyme-linked immunosorbent assays were used to measure the amounts of Ang-2 and VEGF (Quantikine; R&D Systems, Minneapolis, MN, USA). All assays were run in duplicate, with dilutions as appropriate, and the technicians were blinded to clinical data. Figure 2. Correlation between serum Ang-2 and VEGF levels in patients with SPN. There is a significant correlation between Ang-2 and VEGF levels in SPN patients (r=0.441, p<0.001). staged pathologically according to the Union for International Cancer Control (UICC-7) staging system for lung cancer [19]. Histological type was determined according to the classification by the World Health Organization. The demographic and clinical variables of the cases and controls are shown in Table 1. All patients were selected based on presence of SPN on chest CT scan. Final diagnoses were confirmed with histopathologic examinations of specimens obtained by CT-guided transthoracic needle biopsy, transbronchial biopsy, videotape-assisted thoracoscopic surgery, or surgical resection. The study protocol was approved by the ethics committee of Nanjing Chest Hospital. All patients provided written informed consent before enrollment. Sample collection and determination of Ang-2 and VEGF levels. Serum samples from each individual were obtained at the time of diagnosis, before any therapeutic measures were started (surgery, chemotherapy, or Statistical analysis. Statistical software (SPSS for Windows, version 18; SPSS; Chicago, IL) was used for the analysis. All values are given as means± standard deviation except for the survival period in which the mean± standard error was used. The values did not fit a standard distribution, so nonparametric analysis was performed. The Mann-Whitney U test was used to compare the patients and control groups, and the Kruskal-Wallis test was used to compare all groups. Spearman correlation of rank coefficient was used to analyze correlations between parameters. The cutoff value for the serum concentrations of the tested parameters was calculated using a receiver operating characteristic (ROC) curve. The p values of less than 0.05 were considered to be statistically significant. Results Serum levels of Ang-2 and VEGF were elevated in the SPN group. Patients with malignant SPN had higher serum Ang-2 levels than the benign SPN group ( ±599.1 pg/ml vs ±288.6pg/ ml, p<0.01), and the control group ( ±599.1 pg/ml vs 441.2±325.7pg/mL, p<0.01 Figure 1A). Serum VEGF levels were also higher in patients with malignant SPN than in the benign SPN group and the control group (p<0.05, Figure 1B and Table 2). Correlation between serum Ang-2 and VEGF levels. In all patients with SPN, serum Ang-2 significantly correlates with VEGF (r=0.367, p<0.01; Figure 2). Further analysis revealed a significant correlation between serum Ang-2 and VEGF in the malignant SPN group (r=0.486, p<0.01), but not in the benign SPN group.
4 Relationship between serum Ang-2 and VEGF levels and clinicopathological characteristics in malignant SPN. The relationships between Ang-2 and VEGF levels and clinicopathological characteristics of malignant SPN patients are shown in Table 3. The levels of Ang-2 significantly correlate with tumor stage (p=0.033). Conversely, serum VEGF levels did not increase with the stage, although serum VEGF levels in malignant SPN patients with stage II tended to be higher than in those with I stage (p=0.056). The serum Ang-2 and VEGF levels did not differ significantly with age (p=0.981 and 0.206), gender (p=0.932 and 0.766), smoking history (p=0.556 and 0.406), tumor grade (p=0.688 and 0.983) or histology (p=0.943 and 0.133). Diagnostic performance of Ang-2 in malignant SPN. To assess the performance of Ang-2 as a serum marker, ROC curves were used to calculate the sensitivity of this marker in separating malignant SPN patients from healthy volunteers or patients with benign SPN. As shown in Figure 3, an area under the curve (AUC) value for Ang-2 reached and 0.692, respectively. With a cutoff of pg/ml, the sensitivity and specificity of Ang-2 in differentiating between patients with malignant SPN and patients with healthy volunteers, and between patients with malignant SPN and benign SPN was, 80.5 and 97.5%, and 69.5 and 92.5%, respectively. These results indicated that serum Ang-2 was a valuable biomarker for SPN diagnosis (Table 4). Angiopoietin-2 and Solitary Pulmonary Nodules 63 Discussion Figure 3. ROC analysis of Ang-2 for differentiation of patients with malignant SPN from healthy volunteers (A) and from patients with benign SPN (B). The analysis resulted in an AUC of (patients with malignant SPN vs. healthy volunteers) and (patients with malignant SPN vs. patients with benign SPN), respectively. Differentiating malignant SPN from benign SPN has always been a challenge, as most patients are usually asymptomatic. Early detection and diagnosis of SPN are crucial for effective treatment. So far, chest X-ray is usually performed to identify pulmonary nodules as a routine screening test. CT scans and positron emission tomography (PET) scans are both more sensitive and specific than chest X-ray, and are thus employed for further imaging when pulmonary nodules are seen on chest X-rays [20]. However, imaging characteristics cannot distinguish malignant SPN from benign SPN in all patients. So far, a tissue biopsy is the gold standard diagnostic test that can confirm whether the nodules are cancerous or not [5]. However, due to its high cost and invasive nature, most patients are reluctant to undergo tissue biopsy. Therefore, searching for a minimally invasive test to differentiate malignant from benign SPN is very important. Ang plays an important role in cancer growth, maintenance, and metastasis. Ang-1 and 2 act as ligands for Tie2, which is a tyrosine kinase receptor specifically expressed on endothelial cells [21]. Ang-2 antagonizes the stabilizing action of Ang-1 by binding to Tie2 competitively, which destabilizes vessels. It also promotes tumor angiogenesis by priming the vasculature and potentiating the effects of cytokines at the front of active neovascularization [22]. Recent studies have shown that the expression pattern of Ang-2 is strongly associated with that of VEGF in the process of tumor angiogenesis, VEGF and Ang-2 seemed to play complementary and coordinated roles in the development of new blood vessels [23]. Our study aimed to evaluate the diagnostic and prognostic utility of serum Ang-2 levels in SPN patients. We found that serum Ang-2 levels were
5 64 Table 4. ROC curves for serumang-2 to distinguish patients with malignant SPN and healthy volunteers, and patients with malignant SPN and benign SPN. Group Cutoff value Sensitivity Specificity AUC p value 95% CI vs.healthy volunteers pg/mL 80.5% 97.5% vs. benign SPN pg/mL 69.5% 92.5% AUC, Area under the curve; CI, Confidence interval. significantly increased in malignant SPN patients compared with benign SPN and healthy volunteers, making them potential adjunctive tools for diagnosis of SPN. Furthermore, with a cutoff value of pg/ml, serum Ang-2 showed excellent diagnostic performance. Importantly, the serum Ang-2 levels did not differ significantly with age, gender and histology but significantly correlated with stage. This data further reinforced the diagnostic utility of Ang-2 levels in SPN patients. Our study showed a statistical correlation between Ang-2 and VEGF levels in malignant SPN patients. The levels of Ang-2 were related to tumor stage and vascular involvement. Ang-2 overexpression by newly formed tumor blood vessels may lead to vessel destabilization, which could drive the release of VEGF. In conclusion, we have demonstrated the presence of high serum Ang-2 levels in patients with malignant SPN. Ang-2 level can be used as a new diagnostic tool for SPN. Further studies are necessary to clarify the exact role of Ang-2 in malignant SPN growth. References 1. Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med 2003; 348: Sim YT, Poon FW. Imaging of solitary pulmonary nodule-a clinical review. Quant Imaging Med Surg 2013; 3: Brandman S, Ko JP. Pulmonary nodule detection, characterization, and management with multidetector computed tomography. J Thorac Imaging 2011; 26: Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132: 108S-130S. 5. Brader P, Abramson SJ, Price AP, et al. Do characteristics of pulmonary nodules on computed tomography in children with known osteosarcoma help distinguish whether the nodules are malignant or benign? J Pediatr Surg 2011; 46: Harders SW, Madsen HH, Hjorthaug K, et al. Characterization of pulmonary lesions in patients with suspected lung cancer: computed tomography versus [¹⁸F] fluorodeoxyglucose-positron emission tomography/computed tomography. Cancer Imaging 2012; 12: Schuchert MJ, Abbas G, Awais O, et al. Anatomic segmentectomy for the solitary pulmonary nodule and early-stage lung cancer. Ann Thorac Surg 2012; 93: Ghosal R, Kloer P, Lewis KE. A review of novel biological tools used in screening for the early detection of lung cancer. Postgrad Med J 2009; 85: Amur S, Frueh FW, Lesko LJ, et al. Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspective. Biomark Med 2008; 2: Sturgeon CM, Lai LC, Duffy MJ. Serum tumour markers: how to order and interpret them. BMJ 2009; 339: b Tufman A, Huber RM. Biological markers in lung cancer: A clinician's perspective. Cancer Biomark 2010; 6: Park JH, Park KJ, Kim YS, et al. Serum angiopoietin-2 as a clinical marker for lung cancer. Chest 2007; 132: Takahama M, Tsutsumi M, Tsujiuchi T, et al. Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas. Clin Cancer Res 1999; 5: Takanami I. Overexpression of Ang-2 mrna in non-small cell lung cancer: association with angiogenesis and poor prognosis. Oncol Rep 2004; 12: Wong MP, Chan SY, Fu KH, et al. The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas. Lung Cancer 2000; 29: Caine GJ, Blann AD, Stonelake PS, et al. Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1. Eur J Clin Invest 2003; 33: Niedźwiecki S, Stepień T, Kopeć K, et al. Angiopoietin 1 (Ang- 1), angiopoietin 2 (Ang-2) and Tie-2 (a receptor tyrosine kinase) concentrations in peripheralblood of patients with thyroid cancers. Cytokine 2006; 36: Schliemann C, Bieker R, Thoennissen N, et al. Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia. Leukemia 2007; 21: Kassis ES, Vaporciyan AA, Swisher SG, et al. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg 2009; 138: Bunyaviroch T, Coleman RE. PET evaluation of lung cancer. J Nucl Med 2006; 47: Park JH, Choi H, Kim YB, et al. Serum angiopoietin-1 as a prognostic marker in resected early stage lung cancer. Lung Cancer 2009; 66: Fawzy A, Gaafar R, Kasem F, et al. Importance of serum levels of angiopoietin-2 and survivin biomarkers in non-small cell lung cancer. J Egypt Natl Canc Inst 2012; 24: Sun XD, Liu XE, Wu JM, et al. Expression and significance of angiopoietin-2 in gastric cancer. World J Gastroenterol 2004;10:
Comparison of three mathematical prediction models in patients with a solitary pulmonary nodule
Original Article Comparison of three mathematical prediction models in patients with a solitary pulmonary nodule Xuan Zhang*, Hong-Hong Yan, Jun-Tao Lin, Ze-Hua Wu, Jia Liu, Xu-Wei Cao, Xue-Ning Yang From
More informationDiagnostic and prognostic significance of receptor-binding cancer antigen expressed on SiSo cells in lung-cancer-associated pleural effusion
Received: 1 May 2016 Revised: 19 June 2016 Accepted: 10 July 2016 DOI: 10.1111/crj.12527 ORIGINAL ARTICLE Diagnostic and prognostic significance of receptor-binding cancer antigen expressed on SiSo cells
More informationCorrelation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer
Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer X.L. Liu 1, L.D. Liu 2, S.G. Zhang 1, S.D. Dai 3, W.Y. Li 1 and L. Zhang 1 1 Thoracic Surgery,
More informationRatio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer
Original Article Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer Fangfang Chen 1 *, Yanwen Yao 2 *, Chunyan
More informationEndobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer
Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer Dr Richard Booton PhD FRCP Lead Lung Cancer Clinician, Consultant Respiratory Physician & Speciality Director Manchester University NHS
More informationAdam J. Hansen, MD UHC Thoracic Surgery
Adam J. Hansen, MD UHC Thoracic Surgery Sometimes seen on Chest X-ray (CXR) Common incidental findings on computed tomography (CT) chest and abdomen done for other reasons Most lung cancers discovered
More informationMay-Lin Wilgus. A. Study Purpose and Rationale
Utility of a Computer-Aided Diagnosis Program in the Evaluation of Solitary Pulmonary Nodules Detected on Computed Tomography Scans: A Prospective Observational Study May-Lin Wilgus A. Study Purpose and
More informationValidation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules
1 Stanford School of Medicine, Stanford, California, USA; 2 Duke University, Durham, North Carolina, USA; 3 Medical University of South Carolina, Charleston, South Carolina, USA; 4 VA Palo Alto Health
More informationNoninvasive Differential Diagnosis of Pulmonary Nodules Using the Standardized Uptake Value Index
doi: 10.5761/atcs.oa.14-00241 Original Article Noninvasive Differential Diagnosis of Pulmonary Nodules Using the Standardized Uptake Value Index Satoshi Shiono, MD, 1 Naoki Yanagawa, MD, 2 Masami Abiko,
More informationDiagnostic test pepsinogen I and combination with tumor marker CEA in gastric cancer
IOP Conference Series: Earth and Environmental Science PAPER OPEN ACCESS Diagnostic test pepsinogen I and combination with tumor marker CEA in gastric cancer To cite this article: J Sembiring et al 2018
More informationRodney C Richie MD FACP FCCP DBIM Texas Life and EMSI
Rodney C Richie MD FACP FCCP DBIM Texas Life and EMSI Pulmonary Nodules Well-circumscribed, radiographic opacities measuring 3 cm in diameter Surrounded by aerated lung Not associated with atelectesis
More informationApproach to Pulmonary Nodules
Approach to Pulmonary Nodules Edwin Jackson, Jr., DO Assistant Professor-Clinical Director, James Early Detection Clinic Department of Internal Medicine Division of Pulmonary, Allergy, Critical Care and
More informationCharles Mulligan, MD, FACS, FCCP 26 March 2015
Charles Mulligan, MD, FACS, FCCP 26 March 2015 Review lung cancer statistics Review the risk factors Discuss presentation and staging Discuss treatment options and outcomes Discuss the status of screening
More informationDiagnostic challenge: Sclerosing Hemangioma of the Lung. Department of Medicine, Division of Pulmonary and Critical Care, Lincoln Medical and
Diagnostic challenge: Sclerosing Hemangioma of the Lung. S. Arias M.D, R. Loganathan M.D, FCCP Department of Medicine, Division of Pulmonary and Critical Care, Lincoln Medical and Mental Health Center/Weill
More informationValidation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer
Original Article Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Hee Suk Jung 1, Jin Gu Lee 2, Chang Young Lee 2, Dae Joon Kim 2, Kyung Young Chung 2 1 Department
More informationLUNG NODULES: MODERN MANAGEMENT STRATEGIES
Department of Radiology LUNG NODULES: MODERN MANAGEMENT STRATEGIES Christian J. Herold M.D. Department of Biomedical Imaging and Image-guided Therapy Medical University of Vienna Vienna, Austria Pulmonary
More informationDecreased levels of circulating sex hormones as a biomarker of lung cancer in male patients with solitary pulmonary nodules
Decreased levels of circulating sex hormones as a biomarker of lung cancer in male patients with solitary pulmonary nodules Tao Gu 1*, Zongmei Wen 2*, Shufeng Xu 1, Haixia Hua 1, Zhi Zhang 3, Tao Wen 4,
More informationClinical profiles and trend analysis of newly diagnosed lung cancer in a tertiary care hospital of East China during
Original Article Clinical profiles and trend analysis of newly diagnosed lung cancer in a tertiary care hospital of East China during 2011 2015 Pingli Wang 1 *, Jixia Zou 1 *, Jingni Wu 1 *, Chengyan Zhang
More informationCorrelation between serum level of chemokine (C-C motif) ligand 18 and poor prognosis in breast cancer
Correlation between serum level of chemokine (C-C motif) ligand 18 and poor prognosis in breast cancer J.H. Sun 1, N. Fan 2 and Y. Zhang 1 1 Xianyang Hospital of Yan an University Clinical Laboratory,
More informationPET CT for Staging Lung Cancer
PET CT for Staging Lung Cancer Rohit Kochhar Consultant Radiologist Disclosures Neither I nor my immediate family members have financial relationships with commercial organizations that may have a direct
More informationDoes the lung nodule look aggressive enough to warrant a more extensive operation?
Accepted Manuscript Does the lung nodule look aggressive enough to warrant a more extensive operation? Michael Kuan-Yew Hsin, MBChB, MA, FRCS(CTh), David Chi-Leung Lam, MD, PhD, FRCP (Edin, Glasg & Lond)
More informationDiagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD. November 18, 2017
Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD November 18, 2017 Disclosures I do not have a financial interest/arrangement or affiliation with one or more organizations
More informationPredictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer
Original Article Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer Feichao Bao, Ping Yuan, Xiaoshuai Yuan, Xiayi Lv, Zhitian Wang, Jian Hu Department
More informationLos Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010
Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010 Self Assessment Module on Nuclear Medicine and PET/CT Case Review FDG PET/CT IN LYMPHOMA AND MELANOMA Submitted
More informationSerum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer
BIOMEDICAL REPORTS 4: 609-614, 2016 Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer FARUK TAS, ELIF BILGIN, DIDEM TASTEKIN, KAYHAN ERTURK and DERYA DURANYILDIZ Department
More informationOriginal Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical outcome
Int J Clin Exp Pathol 2017;10(2):2030-2035 www.ijcep.com /ISSN:1936-2625/IJCEP0009456 Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical
More informationRight infrahilar nodule
Right infrahilar nodule Search Infrahilar nodule Nov 9, 2015.. CT chest showed a right infrahilar mass 3.5 2.5 cm along with multiple bilateral lung nodules of size 9 to 11 mm. Bronchoscopy. Jun 13, 2015.
More informationCancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006
Chinese Journal of Cancer Original Article Cancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006 Xiao-Pan Li 1, Guang-Wen Cao 2, Qiao
More informationWhen a solitary pulmonary lesion (SPL) is found in
GENERAL THORACIC Resection of Solitary Pulmonary Lesion Is Beneficial to Patients With a History of Malignancy Miki Sakamoto, MD, Tomohiro Murakawa, MD, Kentaro Kitano, MD, Tomonori Murayama, MD, Takehiro
More informationA Clinical Model To Estimate the Pretest Probability of Lung Cancer in Patients With Solitary Pulmonary Nodules*
Original Research CANCER A Clinical Model To Estimate the Pretest Probability of Lung Cancer in Patients With Solitary Pulmonary Nodules* Michael K. Gould, MD, MS, FCCP; Lakshmi Ananth, MS; and Paul G.
More informationThe solitary pulmonary nodule: Assessing the success of predicting malignancy
The solitary pulmonary nodule: Assessing the success of predicting malignancy Poster No.: C-0829 Congress: ECR 2010 Type: Scientific Exhibit Topic: Chest Authors: R. W. K. Lindsay, J. Foster, K. McManus;
More informationThe diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer
European Review for Medical and Pharmacological Sciences 2017; 21: 4039-4044 The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer H.-Y. FAN
More informationSlide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology
Slide 1 Investigation and management of lung cancer Robert Rintoul Department of Thoracic Oncology Papworth Hospital Slide 2 Epidemiology Second most common cancer in the UK (after breast). 38 000 new
More informationIndications and methods of surgical treatment of solitary pulmonary nodule
Original Paper Indications and methods of surgical treatment of solitary pulmonary nodule John Karathanassis 1, Konstantinos Potaris 1, Aphrodite Karathanassis 2, Marios Konstantinou 1, Konstantinos Syrigos
More informationUtility of 18 F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer
Utility of F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer Ngoc Ha Le 1*, Hong Son Mai 1, Van Nguyen Le 2, Quang Bieu Bui 2 1 Department
More informationPrimary pulmonary cancer colliding with metastatic choriocarcinoma
Case Report Primary pulmonary cancer colliding with metastatic choriocarcinoma Zheng Wang 1, Jingwen Si 2, Jingwei Liu 1 1 Department of Thoracic Surgery, 2 Department of Pathology, Peking University First
More informationA nonresponding small cell lung cancer combined with adenocarcinoma
Case Report A nonresponding small cell lung cancer combined with adenocarcinoma Hongyang Lu 1,2, Shifeng Yang 3 1 Zhejiang Key Laboratory of Diagnosis & Treatment Technology on Thoracic Oncology (Lung
More informationExon 19 L747P mutation presented as a primary resistance to EGFR-TKI: a case report
Case Report Exon 19 L747P mutation presented as a primary resistance to EGFR-TKI: a case report Yu-Ting Wang, Wei-Wei Ning, Jing Li, Jian-n Huang Department of Respiratory Medicine, the First ffiliated
More informationWith recent advances in diagnostic imaging technologies,
ORIGINAL ARTICLE Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small Cell Lung Cancer Hong Kwan Kim, MD,* Yong Soo Choi, MD,* Kwhanmien Kim, MD,* Young Mog
More informationSpectrum of Radiological Findings in Bronchogenic Carcinoma A Retrospective Study
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 01 Ver. VIII January. (2018), PP 43-59 www.iosrjournals.org Spectrum of Radiological Findings
More informationLung cancer pleural invasion was recognized as a poor prognostic
Visceral pleural invasion classification in non small cell lung cancer: A proposal on the basis of outcome assessment Kimihiro Shimizu, MD a Junji Yoshida, MD a Kanji Nagai, MD a Mitsuyo Nishimura, MD
More informationThe Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer
Original Article The Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer Chen Qiu, MD,* Wei Dong, MD,* Benhua Su, MBBS, Qi Liu, MD,* and Jiajun Du, PhD Introduction:
More informationPositron Emission Tomography in Lung Cancer
May 19, 2003 Positron Emission Tomography in Lung Cancer Andrew Wang, HMS III Patient DD 53 y/o gentleman presented with worsening dyspnea on exertion for the past two months 30 pack-year smoking Hx and
More informationLung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09
Lung Cancer Imaging Terence Z. Wong, MD,PhD Department of Radiology Duke University Medical Center Durham, NC 9/9/09 Acknowledgements Edward F. Patz, Jr., MD Jenny Hoang, MD Ellen L. Jones, MD, PhD Lung
More informationLung Cancer Staging: The Revised TNM Classification
Norwegian Society of Thoracic Imaging Oslo, October 2011 Lung Cancer Staging: The Revised TNM Classification Sujal R Desai King s College Hospital, London Lung Cancer The Scale of the Problem Leading cause
More informationperformed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.
Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician
More informationPrognostic factors in curatively resected pathological stage I lung adenocarcinoma
Original Article Prognostic factors in curatively resected pathological stage I lung adenocarcinoma Yikun Yang 1, Yousheng Mao 1, Lin Yang 2, Jie He 1, Shugeng Gao 1, Juwei Mu 1, Qi Xue 1, Dali Wang 1,
More informationCombined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer
He et al. BMC Gastroenterology 2013, 13:87 RESEARCH ARTICLE Open Access Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer Chao-Zhu He 1,2, Kun-He Zhang
More informationDownregulation of serum mir-17 and mir-106b levels in gastric cancer and benign gastric diseases
Brief Communication Downregulation of serum mir-17 and mir-106b levels in gastric cancer and benign gastric diseases Qinghai Zeng 1 *, Cuihong Jin 2 *, Wenhang Chen 2, Fang Xia 3, Qi Wang 3, Fan Fan 4,
More informationLung Cancer in Women: A Different Disease? James J. Stark, MD, FACP
Lung Cancer in Women: A Different Disease? James J. Stark, MD, FACP Medical Director, Cancer Program and Director of Palliative Care Maryview Medical Center Professor of Medicine Eastern Virginia Medical
More informationPublished Pulmonary Nodule Guidelines A Synthesis
Published Pulmonary Nodule Guidelines A Synthesis Dr A Devaraj Royal Brompton Hospital London 4/28/2015 1 And very soon to be published Published ^ Pulmonary Nodule Guidelines A Synthesis Dr A Devaraj
More informationMultifocal Lung Cancer
Multifocal Lung Cancer P. De Leyn, MD, PhD Department of Thoracic Surgery University Hospitals Leuven Belgium LEUVEN LUNG CANCER GROUP Department of Thoracic Surgery Department of Pneumology Department
More informationCT Screening for Lung Cancer for High Risk Patients
CT Screening for Lung Cancer for High Risk Patients The recently published National Lung Cancer Screening Trial (NLST) showed that low-dose CT screening for lung cancer reduces mortality in high-risk patients
More informationIn 1989, Deslauriers et al. 1 described intrapulmonary metastasis
ORIGINAL ARTICLE Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases Kanji Nagai, MD,* Yasunori Sohara, MD, Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, and Etsuo Miyaoka,
More informationThe Various Methods to Biopsy the Lung PROF SHITRIT DAVID HEAD, PULMONARY DEPARTMENT MEIR MEDICAL CENTER, ISRAEL
The Various Methods to Biopsy the Lung PROF SHITRIT DAVID HEAD, PULMONARY DEPARTMENT MEIR MEDICAL CENTER, ISRAEL Conflict of Interest This presentation is supported by AstraZeneca Two main steps before
More informationVisceral pleural involvement (VPI) of lung cancer has
Visceral Pleural Involvement in Nonsmall Cell Lung Cancer: Prognostic Significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu, MD, PhD, Sosuke Yamada, MD, and Kosei Yasumoto,
More informationLung Cancer. Public Outcomes Report. Submitted by G. Brooks Brennan, MD. Based on 2015 data
Public Outcomes Report Lung Cancer Submitted by G. Brooks Brennan, MD 2016 Based on 2015 data Lung cancer remains a significant factor in the morbidity and mortality of the United States population. There
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #364: Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines National Quality
More informationA preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer
Original Article Page 1 of 5 A preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer Jia-Wei Wan 1,2 *, Ming-Zhu
More informationImmune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment
Immune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment 1 Introductions Peter Langecker, MD, PhD Executive Medical Director, Global Oncology Clinipace Worldwide Mark Shapiro Vice President
More informationPET/CT in lung cancer
PET/CT in lung cancer Andrei Šamarin North Estonia Medical Centre 3 rd Baltic Congress of Radiology 08.10.2010 Imaging in lung cancer Why do we need PET/CT? CT is routine imaging modality for staging of
More informationLung Cancer Screening
Lung Cancer Screening v Lung Cancer: America s leading cancer killer Annual US cancer mortality 158,040 221,000 new diagnoses in US 4,100 14,180 27,540 Lung 40,560 40,730 49,700 Cervix Ovary Prostate Pancreas
More informationEstablishment of a mathematic model for predicting malignancy in solitary pulmonary nodules
Original Article Establishment of a mathematic model for predicting malignancy in solitary pulmonary nodules Man Zhang 1,2, Na Zhuo 3, Zhanlin Guo 2, Xingguang Zhang 4, Wenhua Liang 5,6, Sheng Zhao 7,
More informationExosomal Del 1 as a potent diagnostic marker for breast cancer : A prospective cohort study
GBCC 2017: ABS-0017 Exosomal Del 1 as a potent diagnostic marker for breast cancer : A prospective cohort study Soo Jung Lee 1, Jeeyeon Lee 2, Jin Hyang Jung 2, Ho Yong Park 2, Chan Hyeong Lee 3, Pyong
More informationCharacteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases Mei Li & Zhi-xiong Lin Department of Radiation
More informationLung Cancer Screening: To Screen or Not to Screen?
Lung Cancer Screening: To Screen or Not to Screen? Lorriana Leard, MD Co-Director of UCSF Lung Cancer Screening Program Vice Chief of Clinical Activities UCSF Pulmonary, Critical Care, Allergy & Sleep
More informationRole of CT imaging to evaluate solitary pulmonary nodule with extrapulmonary neoplasms
Original Research Article Role of CT imaging to evaluate solitary pulmonary nodule with extrapulmonary neoplasms Anand Vachhani 1, Shashvat Modia 1*, Varun Garasia 1, Deepak Bhimani 1, C. Raychaudhuri
More informationAnalysis of gallbladder polypoid lesion size as an indication of the risk of gallbladder cancer
Korean J Hepatobiliary Pancreat Surg 24;8:9-3 http://dx.doi.org/.47/kjhbps.24.8..9 Original Article Analysis of gallbladder polypoid lesion size as an indication of the risk of gallbladder cancer Ji Eun
More informationThe right middle lobe is the smallest lobe in the lung, and
ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,
More informationVisceral pleura invasion (VPI) was adopted as a specific
ORIGINAL ARTICLE Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival Its Implications for the Forthcoming TNM Staging Based on a Large-Scale Nation-Wide Database Junji Yoshida,
More informationDENOMINATOR: All final reports for CT imaging studies with a finding of an incidental pulmonary nodule for patients aged 35 years and older
Quality ID #364: Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines National Quality
More informationSurgical strategies in esophageal cancer
Gastro-Conference Berlin 2005 October 1-2, 2005 Surgical strategies in esophageal cancer J. Rüdiger Siewert Department of Surgery, Klinikum rechts der Isar Technische Universität München Esophageal Cancer
More informationAmerican College Of Radiology ACR Appropriateness Criteria WORK-UP OF THE SOLITARY PULMONARY NODULE
This document is provided to you by the American College of Radiology. We strive to deliver this information in a convenient and effective manner. After you finish reviewing the criteria, please provide
More informationobjectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University
objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University To determine the regions of physiologic activity To understand
More informationThoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis
19 th Congress of APSR PG of Lung Cancer (ESAP): Update of Lung Cancer Thoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis Kazuma Kishi, M.D. Department of Respiratory Medicine,
More informationEvidence based approach to incidentally detected subsolid pulmonary nodule. DM SEMINAR July 27, 2018 Harshith Rao
Evidence based approach to incidentally detected subsolid pulmonary nodule DM SEMINAR July 27, 2018 Harshith Rao Outline Definitions Etiologies Risk evaluation Clinical features Radiology Approach Modifications:
More informationSpecialist Referral Service Willows Information Sheets. Cancer in cats and dogs: Assessment of the patient
Specialist Referral Service Willows Information Sheets Cancer in cats and dogs: Assessment of the patient Cancer in cats and dogs: Assessment of the patient Cancer is common in human and veterinary medicine.
More informationEsophageal Cancer Initially Thought to be Accompanied by a Solitary Metastasis to an Intrathoracic Paraaortic Lymph Node
2012 66 5 417 421 Esophageal Cancer Initially Thought to be Accompanied by a Solitary Metastasis to an Intrathoracic Paraaortic Lymph Node a b* a a a a a a a b ʼ 418 Horio et al. Acta Med. Okayama Vol.
More informationTHE BENEFITS OF BIG DATA
THE BENEFITS OF BIG DATA Disclosures I am a named inventor on a number of patents and patent applications relating to the evaluation of pulmonary nodules on CT scans of the chest which are owned by Cornell
More informationXiang Hu*, Liang Cao*, Yi Yu. Introduction
Original Article Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7 th edition and JCGS 13 th edition N-classification systems Xiang Hu*, Liang
More informationAn Introduction to PET Imaging in Oncology
January 2002 An Introduction to PET Imaging in Oncology Janet McLaren, Harvard Medical School Year III Basics of PET Principle of Physiologic Imaging: Allows in vivo visualization of structures by their
More informationThe detection rate of early gastric cancer has been increasing owing to advances in
Focused Issue of This Month Sung Hoon Noh, MD, ph.d Department of Surgery, Yonsei University College of Medicine E - mail : sunghoonn@yuhs.ac J Korean Med Assoc 2010; 53(4): 306-310 Abstract The detection
More informationMolly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010
LSU HEALTH SCIENCES CENTER NSCLC Guidelines Feist-Weiller Cancer Center Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 Initial Evaluation/Intervention: 1. Pathology Review 2. History and Physical
More informationLow levels of serum mir-99a is a predictor of poor prognosis in breast cancer
Low levels of serum mir-99a is a predictor of poor prognosis in breast cancer J. Li 1, Z.J. Song 2, Y.Y. Wang 1, Y. Yin 1, Y. Liu 1 and X. Nan 1 1 Tumor Research Department, Shaanxi Provincial Tumor Hospital,
More informationCirculating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics Jie Zhang, Jing Gao, Yanyan
More informationGUIDELINES FOR PULMONARY NODULE MANAGEMENT : RECENT CHANGES AND UPDATES
Venice 2017 GUIDELINES FOR PULMONARY NODULE MANAGEMENT : RECENT CHANGES AND UPDATES Heber MacMahon MB, BCh Department of Radiology The University of Chicago Disclosures Consultant for Riverain Medical
More informationExpression of mir-148/152 Family as Potential Biomarkers in Non-Small-Cell Lung Cancer
e-issn 1643-375 Med Sci Monit, 215; 21: 1155-1161 DOI: 1.12659/MSM.89294 Received: 214.11.3 Accepted: 214.11.13 Published: 215.4.23 Expression of mir-148/152 Family as Potential Biomarkers in Non-Small-Cell
More informationCitation Auris, nasus, larynx (2011), 38(3):
TitleManagement of metastasis to the thy Author(s) Ishikawa, Masaaki; Hirano, Shigeru; Citation Auris, nasus, larynx (2011), 38(3): Issue Date 2011-06 URL http://hdl.handle.net/2433/139807 Right 2010 Elsevier
More informationThoracic and head/neck oncology new developments
Thoracic and head/neck oncology new developments Goh Boon Cher Department of Hematology-Oncology National University Cancer Institute of Singapore Research Clinical Care Education Scope Lung cancer Screening
More informationCase Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma.
Case Scenario 1 An 89 year old male patient presented with a progressive cough for approximately six weeks for which he received approximately three rounds of antibiotic therapy without response. A chest
More informationLearning Objectives. 1. Identify which patients meet criteria for annual lung cancer screening
Disclosure I, Taylor Rowlett, DO NOT have a financial interest /arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context
More informationOBJECTIVES. Solitary Solid Spiculated Nodule. What would you do next? Case Based Discussion: State of the Art Management of Lung Nodules.
Organ Imaging : September 25 2015 OBJECTIVES Case Based Discussion: State of the Art Management of Lung Nodules Dr. Elsie T. Nguyen Dr. Kazuhiro Yasufuku 1. To review guidelines for follow up and management
More informationComparison of RECIST version 1.0 and 1.1 in assessment of tumor response by computed tomography in advanced gastric cancer
Original Article Comparison of RECIST version 1.0 and 1.1 in assessment of tumor response by computed tomography in advanced gastric cancer Gil-Su Jang 1 *, Min-Jeong Kim 2 *, Hong-Il Ha 2, Jung Han Kim
More informationElectromagnetic navigational bronchoscopy in patients with solitary pulmonary nodules
Original article Electromagnetic navigational bronchoscopy in patients with solitary pulmonary nodules Samuel Copeland MD, Shrinivas Kambali MD, Gilbert Berdine MD, Raed Alalawi MD Abstract Background:
More informationPET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET
Positron Emission Tomography (PET) When calling Anthem (1-800-533-1120) or using the Point of Care authorization system for a Health Service Review, the following clinical information may be needed to
More informationIndex. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic
More informationMalignant solitary pulmonary nodules: assessment of mass growth rate and doubling time at follow-up CT
Original Article Malignant solitary pulmonary nodules: assessment of mass growth rate and doubling time at follow-up CT Jingxu Li*, Tingting Xia*, Xinguan Yang, Xiao Dong, Jiamin Liang, Nanshan Zhong,
More informationMolecular Imaging and Cancer
Molecular Imaging and Cancer Cancer causes one in every four deaths in the United States, second only to heart disease. According to the U.S. Department of Health and Human Services, more than 512,000
More informationORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery
Nagoya J. Med. Sci. 79. 37 ~ 42, 2017 doi:10.18999/nagjms.79.1.37 ORIGINAL PAPER Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Naoki Ozeki, Koji
More informationSignificance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories
Original Article Significance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories Wu Song, Yulong He, Shaochuan Wang, Weiling
More information